Replies to post #211655 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

CORRECTION

At least one absolute super responder, Subject 107001 ABSOLUTELY AMAZING


Despite the small sample size, Preliminary data demonstrates
Encouraging Safety and Efficacy Signal on both Caregiver &
Clinician-based measures of Severity
• Correlations with Key Biomarker related to disease Pathogenesis
• High Level of Significance: Magnitude of change (Cohen’s d: RSBQ
Total 1.47; Cohen’s d: Glutamate 1.11, Large-Very Large Effect
Sizes), Short duration of treatment, Older age of participants, and
Clinical significance (RSBQ-CGI-I correlations)
• Anavex Rett Syndrome Program consisting of 3 clinical RTT studies
including pediatric ongoing (U.S. RTT, AVATAR and EXCELLENCE)

At least one absolute super responder, Subject 107001 ABSOLUTELY AMAZING

https://www.anavex.com/wp-content/uploads/2019/09/ANAVEX2-73-RS-001-Finland-Conference-Sept-2019-Final.pdf

Good luck and GOD bless,